ArticleBMC cancer2025
Characteristic expression profile of small nucleolar RNAs and their association with tumor immune microenvironment in papillary thyroid carcinoma.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Certain cancers exhibit unique expression profiles of small nucleolar RNAs (snoRNAs), and the aberrant expression of snoRNAs may play significant roles in tumor biology. As the most common endocrine malignancy, the expression pattern and clinical relevance of snoRNAs in papillary thyroid carcinoma (PTC) remain largely unexplored. In this study, we employed small RNA microarray analysis to profile snoRNA expression in tumor tissues and corresponding normal thyroid tissues obtained from patients undergoing thyroidectomy. Differentially expressed snoRNAs (DE-snoRNAs) were validated by quantitative real-time PCR (qRT-PCR) and analysis of The Cancer Genome Atlas (TCGA) database. Furthermore, we applied CIBERSORTx and ESTIMATE algorithms to investigate the association between DE-snoRNA expression levels and clinicopathological features as well as tumor immune microenvironment in PTC. Our results revealed that SNORA68B, SNORA70F, and SNORD88A were downregulated in PTC tissues and potentially associated with the composition and distribution of tumor-infiltrating immune cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.